PCR172 Development of a Novel Patient-Reported Outcome (PRO) Measure to Assess Hormonal-Based Treatment Symptoms and Their Impacts in Patients with Prostate Cancer.
Saved in:
| Title: | PCR172 Development of a Novel Patient-Reported Outcome (PRO) Measure to Assess Hormonal-Based Treatment Symptoms and Their Impacts in Patients with Prostate Cancer. |
|---|---|
| Authors: | Chladek, M1 (AUTHOR), Hunsche, E2 (AUTHOR), Hudgens, S3 (AUTHOR), Brown, B4 (AUTHOR), Fallick, M4 (AUTHOR), dePaauw-Holt, S2 (AUTHOR), Cox, K1 (AUTHOR), Ross, A5 (AUTHOR) |
| Source: | Value in Health. 2022 Supplement, Vol. 25 Issue 7, pS573-S574. 2p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
